OMER FY 2016 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42M+208.1% YoY

Gross Profit

$40M96.6% margin

Operating Income

-$54M-130.4% margin

Net Income

-$67M-160.4% margin

EPS (Diluted)

$-1.65

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$67M

Total Liabilities

$105M

Stockholders' Equity

-$37M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$14M	+208.1%
Gross Profit	$40M	$12M	+222.5%
Operating Income	-$54M	-$71M	+23.8%
Net Income	-$67M	-$75M	+11.1%